Welcome to Definiens Shows and Congresses
We will exhibit or speak at the following events:
The Clinical Trials and Outsourcing Asia Congress will attract over 150 senior-level decision makers working in clinical development, clinical trials and clinical outsourcing from multinational and local pharma and biopharma companies and healthcare institutes from China, Singapore, Australia, Japan, Korea, Thailand, Malaysia. Prominent key leaders from Europe and US will also be represented.
Visit the Definiens booth and attend Dr. Thomas Einert's presentation on Definiens' solutions for biopharma and healthcare institutes.
The 19th Annual Molecular Medicine Tri-Conference is CHI's flagship event. The 2012 program will feature compelling talks from industry, academia, government, and healthcare organizations.
Spanning five days this year, the event now includes more activities including: 2 partnering forums, 5 symposia, 18 short courses, and 12 core programs.
Join over 3,000 attendees in interactive lectures, discussions, and various receptions as a way to facilitate networking opportunities and hearing differing views and perspectives on poignant issues facing you and our industry today.
The focus of the 96. Annual Meeting of the German Society of Pathology will be gastrointestinal pathology and translational research in pathology.
Visit Definines at booth #3.
Changing the paradigm to open the doors to progress across the Drug Discovery & Development Realm. The 5th Annual GDDIF is the leading R&D summit for decision makers, scientific leaders and strategists. It is the only two day gathering dedicated to scientific insights, technolgoy innovation & strategy across the entire R&D realm.
The United States and Canadian Academy of Pathology extends a sincere invitation to the Community of Pathologists to attend its 101st Annual Meeting in Vancouver, British Columbia, Canada. The comprehensive program is structured to meet the scientific and utilitarian needs of students of disease.
Visit the Definiens booth!
Definiens is pleased to announce the 3rd International Definiens Symposium 2012 in Munich. We invite you to our headquarters in the Arnulfpark, Munich and the close-by Ernst & Young Auditorium to hear about cutting-edge biomedical image and data analysis, groundbreaking research, and exchange experiences with other Definiens users. In addition to our dynamic plenary sessions, and fruitful networking breaks, this year we will be adding extensive hands-on workshops to our lineup.
The annual Definiens Symposium is the premier forum for Definiens users and developers from around the world to present their latest research, techniques and workflows. Participants come from research institutions, bio-pharmaceutical companies and the healthcare sector. The Definiens Symposium is one of the leading meetings for biomedical image analysis and related research worldwide and anyone interested in these topics is invited.
The WIN 2012 Symposium will be the next in the successful series of annual meetings dedicated to personalized cancer medicine. The WIN Consortium was created to accelerate the pace and reduce the cost of translating effective cancer treatments to the bedside. The main theme of the 2012 symposium will be efficacy of biomarkers and personalized cancer therapeutics. This theme will be elaborated in various plenary sessions.
Visit us at the Definiens booth to learn more on what we can do to support you in biomarker development and the discovery of personalized cancer therapeutics.
On behalf of the European Society of Pathology and the Society of Czech Pathologists, we would like to warmly invite you to join us in Prague and to be part of the largest gathering of pathologists in Europe in 2012. As both the breadth and depth of information in pathology continues to grow enormously, we believe that we should devote our efforts to developing not only our routine daily practice but also our scientific activity for the overall benefit of patients. Thus, we chose the motto for ECP 2012: Pathology – Science for Patients. We believe that our meeting will attract not only pathologists, but also our clinical colleagues with whom we will discuss many burning questions.
We at Definiens certainly share the ESPs commitment. Visit our booth to learn more.
About Definiens
The Health Image Intelligence Company™
Definiens is a leading Health Image Intelligence™ company that develops software solutions for biomedical image analysis, data mining and clinical decision support. The company’s software analyzes images from cell-based assays, whole tissue slides and full body scans and allows users to correlate this information with data derived from other sources, supporting better decisions in research, diagnostics and therapy.
- Copyright © Definiens
- 2012
- All rights reserved